308 related articles for article (PubMed ID: 22428773)
1. Randomised clinical trial: the effect of baclofen in patients with gastro-oesophageal reflux--a randomised prospective study.
Cossentino MJ; Mann K; Armbruster SP; Lake JM; Maydonovitch C; Wong RK
Aliment Pharmacol Ther; 2012 May; 35(9):1036-44. PubMed ID: 22428773
[TBL] [Abstract][Full Text] [Related]
2. Randomised clinical trial: arbaclofen placarbil in gastro-oesophageal reflux disease--insights into study design for transient lower sphincter relaxation inhibitors.
Vakil NB; Huff FJ; Cundy KC
Aliment Pharmacol Ther; 2013 Jul; 38(2):107-17. PubMed ID: 23721547
[TBL] [Abstract][Full Text] [Related]
3. The effect of baclofen on gastro-oesophageal reflux, lower oesophageal sphincter function and reflux symptoms in patients with reflux disease.
van Herwaarden MA; Samsom M; Rydholm H; Smout AJ
Aliment Pharmacol Ther; 2002 Sep; 16(9):1655-62. PubMed ID: 12197845
[TBL] [Abstract][Full Text] [Related]
4. Effects of baclofen on the functional anatomy of the oesophago-gastric junction and proximal stomach in healthy volunteers and patients with GERD assessed by magnetic resonance imaging and high-resolution manometry: a randomised controlled double-blind study.
Curcic J; Schwizer A; Kaufman E; Forras-Kaufman Z; Banerjee S; Roy S; Pal A; Hebbard GS; Boesiger P; Fried M; Steingoetter A; Schwizer W; Fox M
Aliment Pharmacol Ther; 2014 Nov; 40(10):1230-40. PubMed ID: 25230154
[TBL] [Abstract][Full Text] [Related]
5. Effect of baclofen on gastric acid pocket in subjects with gastroesophageal reflux disease symptoms.
Scarpellini E; Boecxstaens V; Broers C; Vos R; Pauwels A; Tack J
Dis Esophagus; 2016 Nov; 29(8):1054-1063. PubMed ID: 26541138
[TBL] [Abstract][Full Text] [Related]
6. Belching: dyspepsia or gastroesophageal reflux disease?
Lin M; Triadafilopoulos G
Am J Gastroenterol; 2003 Oct; 98(10):2139-45. PubMed ID: 14572558
[TBL] [Abstract][Full Text] [Related]
7. The GABA(B) receptor agonist AZD9343 inhibits transient lower oesophageal sphincter relaxations and acid reflux in healthy volunteers: a phase I study.
Beaumont H; Smout A; Aanen M; Rydholm H; Lei A; Lehmann A; Ruth M; Boeckxstaens G
Aliment Pharmacol Ther; 2009 Nov; 30(9):937-46. PubMed ID: 19650825
[TBL] [Abstract][Full Text] [Related]
8. Arbaclofen placarbil decreases postprandial reflux in patients with gastroesophageal reflux disease.
Gerson LB; Huff FJ; Hila A; Hirota WK; Reilley S; Agrawal A; Lal R; Luo W; Castell D
Am J Gastroenterol; 2010 Jun; 105(6):1266-75. PubMed ID: 20040914
[TBL] [Abstract][Full Text] [Related]
9. Baclofen decreases acid and non-acid post-prandial gastro-oesophageal reflux measured by combined multichannel intraluminal impedance and pH.
Vela MF; Tutuian R; Katz PO; Castell DO
Aliment Pharmacol Ther; 2003 Jan; 17(2):243-51. PubMed ID: 12534409
[TBL] [Abstract][Full Text] [Related]
10. Control of transient lower oesophageal sphincter relaxations and reflux by the GABA(B) agonist baclofen in patients with gastro-oesophageal reflux disease.
Zhang Q; Lehmann A; Rigda R; Dent J; Holloway RH
Gut; 2002 Jan; 50(1):19-24. PubMed ID: 11772961
[TBL] [Abstract][Full Text] [Related]
11. Novel partial 5HT3 agonist pumosetrag reduces acid reflux events in uninvestigated GERD patients after a standard refluxogenic meal: a randomized, double-blind, placebo-controlled pharmacodynamic study.
Choung RS; Locke GR; Francis DD; Katzka D; Winkle PJ; Orr WC; Crowell MD; Devault K; Harmsen WS; Zinsmeister AR; Talley NJ
Neurogastroenterol Motil; 2014 Jan; 26(1):13-20. PubMed ID: 24001105
[TBL] [Abstract][Full Text] [Related]
12. Effect of acute and chronic administration of the GABA B agonist baclofen on 24 hour pH metry and symptoms in control subjects and in patients with gastro-oesophageal reflux disease.
Ciccaglione AF; Marzio L
Gut; 2003 Apr; 52(4):464-70. PubMed ID: 12631652
[TBL] [Abstract][Full Text] [Related]
13. Baclofen improves symptoms and reduces postprandial flow events in patients with rumination and supragastric belching.
Blondeau K; Boecxstaens V; Rommel N; Farré R; Depeyper S; Holvoet L; Boeckxstaens G; Tack JF
Clin Gastroenterol Hepatol; 2012 Apr; 10(4):379-84. PubMed ID: 22079512
[TBL] [Abstract][Full Text] [Related]
14. Effect of the GABA(B) agonist baclofen in patients with symptoms and duodeno-gastro-oesophageal reflux refractory to proton pump inhibitors.
Koek GH; Sifrim D; Lerut T; Janssens J; Tack J
Gut; 2003 Oct; 52(10):1397-402. PubMed ID: 12970129
[TBL] [Abstract][Full Text] [Related]
15. Effect of baclofen on oesophageal motility and transient lower oesophageal sphincter relaxations in GORD patients: a 48-h manometric study.
Grossi L; Spezzaferro M; Sacco LF; Marzio L
Neurogastroenterol Motil; 2008 Jul; 20(7):760-6. PubMed ID: 18373654
[TBL] [Abstract][Full Text] [Related]
16. Does the presence of a hiatal hernia affect the efficacy of the reflux inhibitor baclofen during add-on therapy?
Beaumont H; Boeckxstaens GE
Am J Gastroenterol; 2009 Jul; 104(7):1764-71. PubMed ID: 19491837
[TBL] [Abstract][Full Text] [Related]
17. The effect of an empirical trial of high-dose lansoprazole on symptom response of patients with non-cardiac chest pain--a randomized, double-blind, placebo-controlled, crossover trial.
Bautista J; Fullerton H; Briseno M; Cui H; Fass R
Aliment Pharmacol Ther; 2004 May; 19(10):1123-30. PubMed ID: 15142202
[TBL] [Abstract][Full Text] [Related]
18. The effect of baclofen on nocturnal gastroesophageal reflux and measures of sleep quality: a randomized, cross-over trial.
Orr WC; Goodrich S; Wright S; Shepherd K; Mellow M
Neurogastroenterol Motil; 2012 Jun; 24(6):553-9, e253. PubMed ID: 22404184
[TBL] [Abstract][Full Text] [Related]
19. Randomised clinical trial: effects of monotherapy with ADX10059, a mGluR5 inhibitor, on symptoms and reflux events in patients with gastro-oesophageal reflux disease.
Zerbib F; Bruley des Varannes S; Roman S; Tutuian R; Galmiche JP; Mion F; Tack J; Malfertheiner P; Keywood C
Aliment Pharmacol Ther; 2011 Apr; 33(8):911-21. PubMed ID: 21320138
[TBL] [Abstract][Full Text] [Related]
20. Reflux episodes detected by impedance in patients on and off esomeprazole: a randomised double-blinded placebo-controlled crossover study.
Moawad FJ; Betteridge JD; Boger JA; Cheng FK; Belle LS; Chen YJ; Maydonovitch CL; Wong RK
Aliment Pharmacol Ther; 2013 May; 37(10):1011-8. PubMed ID: 23560727
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
